Aker BioMarine ASA (OSL:AKBM)

Market Cap	8.45B +48.1%
Revenue (ttm)	2.14B +9.4%
Net Income	-365.56M
EPS	n/a
Shares Out	87.70M
PE Ratio	n/a
Forward PE	40.15
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,584
Average Volume	41,502
Open	96.40
Previous Close	96.40
Day's Range	96.10 - 97.00
52-Week Range	43.65 - 100.80
Beta	0.36
RSI	51.41
Earnings Date	Feb 12, 2026

About Aker BioMarine ASA

Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name. ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 249
• Stock Exchange: Oslo Børs
• Ticker Symbol: AKBM

Financial Performance

Financial numbers in USD